Sentieon Inc.

San Jose, CA

UEI
GSJUN6H5PFN1
CAGE
81RV0
Primary NAICS
513210 Software Publishers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Parking lot, 160 E Tasman Dr #208, San Jose, CA 95134, USA
Website
sentieon.com
Founded
2014
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $20,000
FY2025 $0
FY2024 $18,000
FY2023 $12,000

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $20,000

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Sentieon Inc., a self-certified small disadvantaged business based in San Jose, California, supplies proprietary bioinformatics and genomic data analysis software to federal research agencies as a prime contractor, operating exclusively in full-and-open competition with no set-aside designations across its federal footprint.

Sentieon specializes in software tools for processing and analyzing whole genome sequencing data, with a capability portfolio centered on DNAseq, DNAscope, TNseq, and TNscope bioinformatics pipelines. The company's recent federal work consists entirely of software license renewals and subscriptions supporting genomic research initiatives. Representative work includes a $20 thousand purchase order awarded by the National Cancer Institute on March 20, 2026, to renew an annual software license subscription through March 19, 2027; an $18 thousand purchase order from NCI awarded September 16, 2024, for bioinformatics software supporting whole genome sequencing; a $12 thousand NCI purchase order dated September 1, 2023, for proprietary software supporting the Never Smokers Study; and a $20 thousand Food and Drug Administration Total Small Business purchase order awarded September 15, 2021, for genomic research and analysis software. All awards are firm fixed-price purchase orders with no subcontractor involvement.

Customer concentration is heavily concentrated with the National Cancer Institute, which accounts for 7 of 9 awards and $101 thousand of the combined $133 thousand potential value (76% of the portfolio). The Food and Drug Administration and the NIH Clinical Center each hold one award. All customer agencies sit within the Department of Health and Human Services. The federal award footprint is classified as Software Publishers under NAICS, with perpetual-license and information-technology software delivery under PSC codes.

Activity over the past five years shows minimal volume — nine total awards across 2021 through 2026 — with sporadic annual placement (two awards in 2021, one each in 2022, 2023, and 2024, and one in 2026). One award reaches ultimate completion within the next twenty-four months, carrying $20 thousand in potential value and therefore exposing one license renewal to recompete. The vendor maintains no position on government-wide vehicles, BPAs, or agency IDIQs; all work flows through direct purchase orders issued by customer agencies.

Quick answers

Is Sentieon Inc. registered in SAM.gov?

Yes. Sentieon Inc.'s SAM.gov registration is active through February 18, 2027.

What is Sentieon Inc.'s CAGE code?

Sentieon Inc.'s CAGE code is 81RV0, and its Unique Entity ID (UEI) is GSJUN6H5PFN1.

How much has Sentieon Inc. received in federal contracts?

Federal contracts obligated $50,000 to Sentieon Inc. in fiscal years 2023 through 2027.

What is Sentieon Inc.'s most recent federal award?

Sentieon Inc.'s most recent federal contract award is The purpose of this requirement is to renew the annual sentieon license subscription for 1 year (75N91026P00013), from National Cancer Institute (NIH), on March 20, 2026.

On GovTribe

See Sentieon Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe